Equity Research Medical Care Facilities

Should You Buy Concentra Group Holdings Parent, Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 11/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Concentra Group Holdings Parent, Inc. (CON) occupies a solid middle-ground position with a Quality of Company score of 7.5/10. At the current market price of $35.62, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.

The short answer: 1 of 11 CirclFi valuation models project upside for Concentra Group Holdings Parent, Inc. (CON) at $35.62 — the model consensus leans bearish, with a Quality Score of 7.5/10 and Value-Trap risk of 17/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 10 of 11 models suggest overvaluation — majority bearish
  • Quality Score: 7.5/10 — Strong — above-average quality
  • Value Trap Risk: 17/100 — Minimal — healthy fundamentals
  • Fair Value Range: $6.85 – $47.99 (601% spread)

Bullish Models

1 / 11

Bearish Models

10 / 11

Quality Score

7.5 /10

Strong — above-average quality

Value Trap Risk

17 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

11 /13
Active Models

Avg. confidence: 51%

What Is the Investment Case for Concentra Group Holdings Parent, Inc. (CON) in 2026?

What Is the Bull Case vs the Bear Case for Concentra Group Holdings Parent, Inc. (CON)?

Bull case versus bear case for Concentra Group Holdings Parent, Inc. (CON) at $35.62, derived from 11 active CirclFi valuation models on 2026-09-15.
Bull case — $47.99 target (+34.7%) Bear case — $6.85 target (-80.8%)
According to the CirclFi Quality of Company (QOC) framework, Concentra Group Holdings Parent, Inc.'s quality score of 7.5/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation. According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $6.85 (-80.8%), suggesting that the market price embeds overly optimistic growth assumptions.
According to the CirclFi Deep Alpha Valuation Engine, the First Chicago model targets a fair value of $47.99 (+34.7%), anchoring the bull case with a methodology that evaluates base, bull, and bear scenarios simultaneously. According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +115.5% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology.

How Does CON Compare to Its Medical Care Facilities Peers?

DVA DaVita Inc.
7.5
FMS Fresenius Medical Ca
7.3
GRDN Guardian Pharmacy Se
7.6
JYNT The Joint Corp.
7.2
BTMD biote Corp.
7.6
LFST LifeStance Health Gr
7.2
MCTA Charming Medical Lim
6.1
BICX BioCorRx Inc.
4.9

Valuation data pages: DVA · FMS · GRDN · JYNT · BTMD · LFST · MCTA · BICX · ENSG · ADUS · NHC

See full Medical Care Facilities rankings →

Which Other Stocks Score Like CON on Quality?

Closest companies to CON’s Quality of Company score of 7.5/10, across all industries.

Why Do CirclFi’s 11 Models Disagree on CON?

Spread

601%

Fair Value Range

$6.85 – $47.99

A 601% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

First Chicago

$47.99 (+34.7%)

Most Bearish

EROIC

$6.85 (-80.8%)

What Are the Biggest Risks of Buying CON Stock?

Model Disagreement

601% spread signals high variance in projections.

Bearish Consensus

10/11 models suggest overvaluation.

Macro/Sector Risk

Medical Care Facilities headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View CON Data Page →

So Is Concentra Group Holdings Parent, Inc. (CON) Worth Buying in 2026?

Our valuation engine sends a clear cautionary signal on Concentra Group Holdings Parent, Inc. at $35.62. 10/11 models flag overvaluation, median fair value sits at $17.71 (-50.3%), and the risk-reward profile appears unfavorable. Quality at 7.5/10 is the one bright spot, but premium quality at the wrong price can still destroy returns. This is a stock where patience — or avoidance — may be the optimal strategy.

These are quantitative model outputs, not investment recommendations. Concentra Group Holdings Parent, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About CON Stock?

Should I buy CON stock right now?

Based on CirclFi's multi-model analysis, 1 of 11 models see upside for CON at $35.62. The models are divided, which means the investment case depends heavily on your assumptions about Concentra Group Holdings Parent, Inc.'s future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Concentra Group Holdings Parent, Inc.?

Key risks include: wide model disagreement (601% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.

How does CON compare to its competitors?

Among Medical Care Facilities peers, CON holds a Quality Score of 7.5/10. Comparable companies include DVA (QOC 7.5), FMS (QOC 7.3), GRDN (QOC 7.6). The relative ranking helps investors identify whether CON offers better fundamental quality than alternatives in the same sector.

Is CON a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CON's Quality Score of 7.5/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy CON at?

CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $6.85 to $47.99. At $35.62, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for CON.

View CON Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →